Tag: TAVI
No difference in event rates for secondary access strategies during TAVI
Using a transradial appro...
EuroPCR 2026: Routine PCI provides “limited advantage” compared with medical therapy following TAVI
Routine percutaneous ...
EuroPCR 2026: SMART trial three-year data demonstrate superiority for Evolut TAVI system
Medtronic today relea...
US FDA gives approval to commercialise AI software to guide transcatheter procedures
Caranx Medical has an...
Trial comparing TAVI and SAVR in aortic regurgitation enrols first patients
JenaValve has announced t...
Improved survival seen following TAVI explant compared to redo procedures
Analysis of real-world US...
Study intensifies call for randomised trial in patients with bicuspid aortic stenosis
The results of a retr...
Stroke rates diverge among TAVI and surgery patients at five years in pragmatic trial
Long-term results of ...
SoloPace announces US FDA clearance and first-in-human use of TAVI temporary pacing system
SoloPace Incorporated has...
Transverse Medical completes first patient series involving Point-Guard CEP device
Transverse Medical has an...
Post-TAVI pacemaker implantation linked to long-term increase in mortality rates
Pacemaker implantatio...
ACC.25: ALIGN-AR reports positive outcomes with dedicated TAVI device for aortic regurgitation
Data from 500 patient...
CRT 2025: New TAV-in-SAV data underline importance of aortic valve sizing at index procedure
New data on the outco...
CRT 2025: Improved haemodynamics seen with supra-annular TAVI system at two years in SMART trial
Two-year results of t...
PCI should be standard of care in patients with coronary artery disease undergoing valve replacement
Performing percutaneo...
Robotic aortic valve replacement offers an “exciting new chapter” in the treatment of aortic valve disease
The rapid growth of trans...
PCR London Valves 2024: New data presented alongside launch of latest-generation Myval device
New analysis of the M...
ACURATE IDE results put spotlight on impact of valve under-expansion after TAVI
“Disappointed is an u...
First patient procedures performed with Abbott’s balloon-expandable TAVI system
Abbott has announced ...
Advertorial: Newest-generation TAVI platforms designed to meet the demands of the modern cath lab
This advertorial is spons...
TCT 2024: EARLY TAVR shows early intervention may be fruitful in asymptomatic aortic stenosis
EARLY TAVR lived up t...
First two TAVI procedures completed using Venus-Vitae valve in SMART ALIGN trial
Venus Medtech has ann...
ESC 2024: TAVI “superior” to surgery in women with severe aortic stenosis
The first trial comparing...
AI models have potential in heart team decision-making, but beware blindspots
Large language models...
NOTION-2 trial: What are the implications for TAVI in young, low-risk patients with bicuspid valves?
Ole De Backer (Copenhag...
First-in-human results with Mirus Siegel TAVI valve presented at New York Valves 2024
Initial experience wi...
Investigators find small reduction in disabling stroke from embolic protection device use
Analysis of data from...
New York Valves hears five-year data from PARTNER trials focused on small annulus patients
Results of an analysi...
EuroPCR 2024: SMART trial data offer new insight on TAVI device choice in women
Data from the SMART t...
Advertorial: TAVI in small aortic annuli: SMART trial underscores importance of choosing the right device
This advertorial is spons...
PROTEMBO randomised trial of three-vessel cerebral embolic protection device enrols first patient
Protembis has announced t...
ADVERTORIAL: TAVI offers promise in the “underdiagnosed and undertreated” aortic regurgitation population
This advertorial is spons...
Early feasibility study of TAVI platform for treatment of aortic regurgitation completes enrolment
Genesis MedTech has annou...
STS 2024: Data show shift in the proportion of patients under 60 receiving TAVI instead of SAVR
Research presented at...
Chilean centre treats five aortic regurgitation patients in a single day with Zeta TAVI system
Laguna Tech USA has annou...
Projected rise in aortic valve-in-valve procedures prompts interest in leaflet splitting device
Details of the first ...
TAVI operators should master multiple techniques to avoid coronary obstruction
In order to avoid cor...
EuroPCR 2023: FAST-TAVI II highlights benefits of reducing length of stay after TAVI procedures
Implementation of a ...
ADVERTORIAL: “No stroke is innocent”: Why stroke matters for TAVI patients
This advertorial is spons...
ACC 2023: Benefit of TAVI “consistent” over first three years in low risk patients
Three-year results fr...
HOSPITAVI elucidates underlying causes of rehospitalisations among TAVI patients
A single-centre retr...
TAVI pioneers discuss the past, present and future of transcatheter therapy
As transcatheter aor...
Hospitals without high-level designation more likely to miss strokes following TAVI procedures
A study conducted by Mich...
US FDA approves use of Navitor TAVI valve in high-risk aortic stenosis patients
The US Food and Drug Admi...
EuroPCR 2022: Lifetime management is an important question for the evolution of TAVI
Matti Adam (Cologne,...
ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI
Edoxaban is noninferi...
Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR
John Forrest (New Ha...
EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients
Complete two-year fol...
SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique
Medtronic has announc...
CRT 2020: Stage 3 kidney injury after TAVI leads to seven times higher mortality
Patients who develop ...
Self-expanding and balloon-expandable valves are equally effective in high-risk TAVI
A comparison of newer...
STS 2020: Young patients with aortic valve disease do better with SAVR than TAVI
Open heart surgery re...
Selecting the right valve for the patient is key for a successful TAVI program
NOTE: This video is ONLY ...
Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results
George Dangas (Mount ...
PCR London Valves 2019: A simple algorithm can reduce unnecessary pacemaker implantation after TAVI
Permanent pacemaker impla...
Pre-TAVI aortic regurgitation aids survival post-TAVI in mixed aortic valve disease patients
Patients who have mix...
TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved TAVI systems
The Portico IDE study...
ADVERTORIAL: Device and procedural innovations have led to improved efficiency with TAVI
Caution: This content...
NICE issues recommendations on insertion of cerebral protection devices during TAVI
The National Institute fo...
PCR statement on TAVI signals “paradigm shift” in treatment of severe symptomatic AS
Evolving indications ...
ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients
Evidence for the use of t...
Shockwave Intravascular Lithotripsy (IVL) helps facilitate first-choice transfemoral access for TAVR
Carlo Di Mario (Flor...
SCCT releases new guideline for use of computed tomography in TAVR procedure
The Society of Cardio...
TAVI is increasingly seen as the preferred approach for aortic valve replacement in CABG patients
A review of the trend...
Depression significantly increases mortality after aortic valve replacement
Data from the FRALITY...
Next-day discharge appears safe for TAVI patients without in-hospital complications
Patients who undergo ...
Modifying procedural technique during TAVI may lower radiation exposure to patients
Andrew Goldsweig (Div...
No significant differences in post TAVI outcomes between African Americans and Caucasians
Fahad Alqahtani (Divi...
All-comers data indicate stroke-free survival is improved with Sentinel embolic protection device
Jochen Wöhrle (Depart...
CoreValve Evolut can be used to treat intermediate-risk patients in the USA
Medtronic has announc...
Essential Frailty Toolset may be best assessment of frailty for aortic stenosis patients
Jonathan Afilalo (Div...
Unique 3D-printed heart valves could reduce TAVI paravalvular leakage rates
Researchers at Georgia In...
Nearly one in 10 US TAVI procedures is off label but results seem acceptable
Ravi S Hira (Section ...
EuroPCR 2017: Study provides “first step” towards showing long-term durability of TAVI devices
New data presented, b...
Study confirms that volume matters for achieving lower in-hospital mortality after TAVI
A study, published in...
EuroPCR 2017: Greater risks with standard approach of dual antiplatelet therapy after TAVI
The ARTE study, which...
TVT 2017: “I predict a very exciting and bright future” for transcatheter valve therapies
This year marks the 1...
EuroPCR 2017: Excellent early outcomes for Edwards Lifesciences’ self-expanding valve
According to late-bre...
EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at one year
Data from the REPRISE III...
Reduced baseline left ventricular function may explain female survival benefit after TAVI
A new study indicates...
First patients enrolled in HLT’s Meridian transcatheter aortic valve feasibility study
HLT has announced that th...
ACC 2017: TAVI Linked with bleeding in the brain and neurological impairment
Of 84 older patients ...
TAVI may benefit certain heart valve patients, update society guidelines say
New recommendations have ...
FDA advisory panel recommend de novo approval of Sentinel cerebral protection system
In an open public hea...
Locking mechanism problems prompt Boston Scientific to recall all ranges of its Louts TAVI device
According to Reuters,...
New guidelines released to improve stroke reporting following cardiac procedures
In response to a grow...
TAVI company Direct Flow Medical closes after failing to secure funding
Direct Flow Medical, whic...
Perform PCI prior to TAVI in patients with both coronary artery disease and aortic stenosis
Stephen Ramee (Ochsne...
Women fare better than men one year after transcatheter aortic valve implantation
Women with significan...
TCT 2016: SENTINEL trial fails to meet overall primary efficacy endpoint but does in adjusted model
The SENTINEL trial, w...
FDA clear temporary pacing lead for use during TAVI and other cardiovascular applications
BioTrace Medical has ...
TAVI is “technically feasible” for managing aortic regurgitation in high-risk patients
Anna Franzone (Depart...
Claret Medical submits application for FDA approval of its cerebral protection device
Claret Medical has an...
Sapien 3 now approved for intermediate-risk patients in Europe as well as in the USA
Following last month’...
TCT 2016: Pivotal trial on cerebral protection device to be presented as a late-breaker
Data from the SENTINE...
Boston Scientific issues urgent recall of Lotus systems manufactured prior to March 2016.
Boston Scientific has...
